COMPARISON OF THE WESTERN IMMUNOBLOT ASSAY AND A GLYCOPROTEIN-G ENZYME-IMMUNOASSAY FOR DETECTION OF SERUM ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-2 IN PATIENTS WITH AIDS JOURNAL OF CLINICAL MICROBIOLOGY Safrin, S., Arvin, A., Mills, J., Ashley, R. 1992; 30 (5): 1312-1314

Abstract

Herpes simplex virus type 2 (HSV-2) seroprevalence in 68 patients with AIDS was 77% by Western blot (immunoblot) and 44% by glycoprotein G-2 immunoassay. Each of 16 patients with culture-proven HSV-2 infection was positive by Western blot versus 8 by glycoprotein G-2 immunoassay. No differences in age, race, duration of AIDS, acyclovir usage, or HSV-1 seroprevalence were found to explain differences in sensitivity.

View details for Web of Science ID A1992HP82800052

View details for PubMedID 1316370